Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment

Int J Clin Pharmacol Res. 1985;5(5):309-18.

Abstract

In a single-blind cross-over study the effect of oral treatment with pantethine on plasma and platelet lipid composition was evaluated in 20 patients with dyslipidaemia (7 IIa, 7 IIb and 6 Iv type). In plasma significant decreases of total cholesterol and triglycerides with increase of high density lipoprotein-cholesterol were observed. In platelets pantethine treatment significantly reduced phospholipid and cholesterol content. In addition gas-chromatographic analysis showed a reduction of saturated and monounsaturated and a relative increase of polyunsaturated fatty acid content of platelet phospholipids. A selective relative increase was observed of some n-3 polyunsaturated fatty acids like eicosapentaenoic and docosahexaenoic acid whereas arachidonic acid decreased. The present study indicates a favourable influence of pantethine not only on plasma but also on platelet lipids which could be of value in delaying the development of atherosclerosis in dyslipidaemic patients.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Blood Platelets / analysis*
  • Blood Platelets / drug effects
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Chromatography, Gas
  • Fatty Acids / blood*
  • Female
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type IV / blood
  • Male
  • Middle Aged
  • Pantetheine / administration & dosage
  • Pantetheine / analogs & derivatives
  • Pantetheine / therapeutic use*
  • Phosphatidylcholines / blood
  • Phosphatidylethanolamines / blood
  • Phospholipids / blood*
  • Sulfhydryl Compounds / therapeutic use*
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Fatty Acids
  • Phosphatidylcholines
  • Phosphatidylethanolamines
  • Phospholipids
  • Sulfhydryl Compounds
  • Triglycerides
  • Pantetheine
  • pantethine
  • Cholesterol